|
| 1 |
Characterization of a conjugated polysuccinimide-carboplatin compound
Sun Young Lee, Chang Hoon Chae, Miklós Zrínyi, Xiangguo Che, Je Yong Choi, Dong-Hyu Cho
|
|
| 2 |
Metastatic ameloblastoma with postoperative accelerated tumor growth treated with carboplatin and paclitaxel: a case report
Joo Un Park, Jae Wan Jung
Kosin Med J.2022;37(1):83-88. Published online 2022 March 23
DOI: http://dx.doi.org/10.7180/kmj.21.030
|
|
| 3 |
Use of Gemcitabine Plus Carboplatin Is Associated with Poor Outcomes in Urothelial Carcinoma Patients with Chronic Kidney Disease Stage 4–5
Hyung-Don Kim, Hyeon-Su Im, Jwa Hoon Kim, Hyehyun Jeong, Shin Kyo Yoon, Inkeun Park, Jae Lyun Lee
Cancer Res Treat.2021;53(4):1166-1173. Published online 2021 March 4
DOI: http://dx.doi.org/10.4143/crt.2021.091
|
|
| 4 |
A Case of Recurrent Cervical Cancer Responded to Paclitaxel and Carboplatin Combination
Hyun Hoon Chung, Jae Weon Kim, Moon Hong Kim, Joo Won No, Noh Hyun Park, Yong Sang Song, Soon Beom Kang, Hyo Pyo Lee, Seong Il Kim, Taek Sang Lee
|
|
| 5 |
Comparison Between Paclitaxel-Carboplatin and Paclitaxel-Cisplatin as a Combination Chemotherapy in Recurrent Ovarian Cancer
Hang Jo Yoo, Yong Man Kim, Hea Rim Lee, Mi Kyung Kim, Dong Heon Lee, Jong Hyeok Kim, Young Tak Kim, Jung Eun Mok, Joo Hyun Nam
|
|
| 6 |
A Comparative Study of the Toxicity Between carboplatin and Cisplatin in VBP Combination Chemotherapy
Pan Young Kim, Hee Sung Seo, Jung Ok Shin, Kyung Taeck Jang, Dong Han Bae
|
|
| 7 |
The Response Rate of Carboplatin/Paclitaxel for the Platinum Sensitive Recurrent Ovarian Cancer Patients
Hye Jin Chang, Hee Sug Ryu, Yun Kyoung Lim, Se Hee Moon, Ki Hong Chang, Jung Pil Lee
|
|
| 8 |
Efficacy of palonosetron plus dexamethasone in preventing chemotherapy-induced nausea and emesis in patients receiving carboplatin-based chemotherapy for gynecologic cancers: a phase II study by the West Japan Gynecologic Oncology Group (WJGOG 131)
Shin Nishio, Satomi Aihara, Mototsugu Shimokawa, Akira Fujishita, Shuichi Taniguchi, Toru Hachisuga, Shintaro Yanazume, Hiroaki Kobayashi, Fumihiro Murakami, Fumitaka Numa, Kohei Kotera, Naofumi Okura, Naoyuki Toki, Masatoshi Yokoyama, Kimio Ushijima
|
|
| 9 |
Long-Term Survival Analysis of Intraperitoneal versus Intravenous Chemotherapy for Primary Ovarian Cancer and Comparison between Carboplatin- and Cisplatin-based Intraperitoneal Chemotherapy
Kyung Jin Eoh, Jung-Yun Lee, Eun Ji Nam, Sunghoon Kim, Young Tae Kim, Sang Wun Kim
|
|
| 10 |
Long-term recurrence-free survival of a patient with advanced pure primary ovarian squamous cell carcinoma treated with dose-dense paclitaxel combined with carboplatin
Hiroyuki Yazawa, Tsuyoshi Hiraiwa, Fumihiro Ito, Keiya Fujimori
|
|
| 11 |
Crizotinib versus Chemotherapy in Asian Patients with ALK-Positive Advanced Non-small Cell Lung Cancer
Makoto Nishio, Dong-Wan Kim, Yi-Long Wu, Kazuhiko Nakagawa, Benjamin J. Solomon, Alice T. Shaw, Satoshi Hashigaki, Emiko Ohki, Tiziana Usari, Jolanda Paolini, Anna Polli, Keith D. Wilner, Tony Mok
|
|
| 12 |
An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021)
Shin-Wha Lee, Yong-Man Kim, Chi Heum Cho, Young Tae Kim, Seok Mo Kim, Soo Young Hur, Jae-Hoon Kim, Byoung-Gie Kim, Seung-Cheol Kim, Hee-Sug Ryu, Soon Beom Kang
Cancer Res Treat.2018;50(1):195-203. Published online 2017 March 21
DOI: http://dx.doi.org/10.4143/crt.2016.376
|
|
| 13 |
An open-label, multicenter, phase I trial of a cremophor-free, polymeric micelle formulation of paclitaxel combined with carboplatin as a first-line treatment for advanced ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG-3016)
Shin-Wha Lee, Yong-Man Kim, Young Tae Kim, Soon Beom Kang
|
|
| 14 |
Effect Of Vpp/Cav Alternating Chemotherapy Versus Carboplatin/Etoposide(Ce) Chemotherapy For Extensive Stage Small Cell Lung Cancer
Sun Young Kim, Jae Chul Suh, Myung Hoon Kim, Hee Sun Park, Dong Won Kang, Kyu Seung Lee, Dong Seok Ko, Geun Hwa Kim, Seong Su Jeong, Ju Ock Kim
|
|
| 15 |
Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine
Choong-kun Lee, Minkyu Jung, Hye Jin Choi, Hye Ryun Kim, Hyo Song Kim, Mi Ryung Roh, Joong Bae Ahn, Hyun Cheol Chung, Su Jin Heo, Sun Young Rha, Sang Joon Shin
Cancer Res Treat.2015;47(4):781-789. Published online 2015 February 16
DOI: http://dx.doi.org/10.4143/crt.2014.261
|
|
| 16 |
Use of colony-stimulating factor in patients with ovarian cancer receiving paclitaxel and carboplatin in Japan
Kenichi Harano, Akihiro Hirakawa, Takayuki Kato, Keisuke Suzuki, Sachiko Watanabe, Noriyuki Katsumata
|
|
| 17 |
A Case of Pathologic Nystagmus following Chemotherapy Using Carboplatin for Small Cell Lung Cancer -A Case Report-
Ji Yong Kim, Jung Hyun Park, Jin Hyong Lee, Hyoung Seop Kim
|
|
| 18 |
Phase II Study of Consolidation Chemotherapy after Adjuvant or Primary Concurrent Chemoradiation Using Paclitaxel and Carboplatin to Treat High-Risk Early-Stage or Locally Advanced Cervical Cancer
Hee Seung Kim, Mi-Kyung Kim, Hak Jae Kim, Seung-Su Han, Jae Weon Kim
|
|
| 19 |
Phase II Clinical Trial of Genexol® (Paclitaxel) and Carboplatin for Patients with Advanced Non-small Cell Lung Cancer
Han Jo Kim, Kyoung Ha Kim, Jina Yun, Se Hyung Kim, Hyun Jung Kim, Sang-Cheol Lee, Sang Byung Bae, Chan Kyu Kim, Nam Su Lee, Kyu Taek Lee, Do-Jin Kim, Seong-Kyu Park, Jong-Ho Won, Dae Sik Hong, Hee Sook Park
|
|
| 20 |
N-Acetylcysteine and N-Nitroarginine Methyl Ester Attenuate Carboplatin-Induced Ototoxicity in Dissociated Spiral Ganglion Neuron Cultures
Il Joon Moon, Ki Ryung Kim, Ho-Suk Chu, Se Hyung Kim, Won-Ho Chung, Yang-Sun Cho, Sung Hwa Hong
|
|
